Search
for
Sort by
Research 811–840 of 1000+
- Orthostatic symptoms in women treated with low-dose oral minoxidil in the absence of overt hypotension: Implications for clinical practice
- Safety and tolerability of low-dose oral minoxidil in adolescents: A retrospective review
- Low-level laser therapy for androgenic alopecia
- Hairy drinking may cause severe hangover symptoms in patients taking low‐dose minoxidil
- Non-invasive monitoring of low molecular weight biomarkers relevant to skin inflammation and cancer
- Long‐Term Efficacy and Safety of Low‐Level Laser Therapy for Androgenetic Alopecia: A 12‐Month Prospective Trial
- Low-dose oral minoxidil in a case of short anagen syndrome
- Low‐Dose Oral Minoxidil and Associated Adverse Events: Analyses of the FDA Adverse Event Reporting System (FAERS) With a Focus on Pericardial Effusions
- Does low-energy fractional carbon dioxide laser therapy improve hair regrowth in female-pattern hair loss?
- The Role of Light-Matter Interactions in Low-Fluence Photo-Induced Hair Removal
- Dermatologists’ Knowledge, Attitude, and Practice Pattern Toward Low-Dose Oral Minoxidil in Hair Loss in Saudi Arabia
- Comparative Efficacy of 2% Minoxidil Alone Against Combination of 2% Minoxidil and Low-level Laser therapy in Female Pattern Hair Loss-A Randomized Controlled Trial in Chinese females
- Novel Treatment Modalities for Hair Loss
- Low Level Laser Treatment for Patterned Hair Loss: A Systematic Review
- Cardiovascular Safety Signals of Oral Versus Topical Minoxidil in FAERS: A Disproportionality Analysis (Analytic Cohort 2012–2025)
- Randomized controlled trial to compare the efficacy of oral minoxidil 1.25 mg versus 2.5 mg versus topical 5% minoxidil in androgenetic alopecia
- Toxicity Assessment of a Single Dose of Poly(ethylene glycol) Diglycidyl Ether (PEGDE) Administered Subcutaneously in Mice
- Low-Dose Dimethyl Sulfoxide (DMSO) Suppresses Androgen Receptor (AR) and Its Splice Variant AR-V7 in Castration-Resistant Prostate Cancer (CRPC) Cells
- The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus
- Low-Molecular-Weight Synthetic Antioxidants: Classification, Pharmacological Profile, Effectiveness and Trends
- K6/ODC transgenic mice as a sensitive model for carcinogen identification
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- Photobiomodulation: A Systematic Review of the Oncologic Safety of Low-Level Light Therapy for Aesthetic Skin Rejuvenation
- Chronic toxicity of 3,4,3′,4′-tetrachlorobiphenyl in the marmoset monkey (Callithrix jacchus)
- The prostaglandin synthases, COX-2 and L-PGDS, mediate prostate hyperplasia induced by low-dose bisphenol A
- Topical Treatment for Scarring and Non-Scarring Alopecia: An Overview of the Current Evidence
- Niosomes as Carrier in Dermal Drug Delivery
- Preliminary toxicity profile of arotinoids SMR-2 and SMR-6 in male B6D2F1 mice*1
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- Long-term detection of methyltestosterone (ab-) use by a yeast transactivation system